Showing results (401-410 of 445) with videos related to
Sort By:
Pageof 45
Acta Neurochirurgica|March 19, 2021
Petroclival meningiomas: update of current treatment and consensus by the EANS skull base sectionLorenzo Giammattei, P di Russo, D Starnoni, et al.Neuro-Oncology Advances|December 23, 2020
Clinical, radiologic, and genetic characteristics of histone H3 K27M-mutant diffuse midline gliomas in adultsJessica D Schulte, Robin A Buerki, Sarah Lapointe, et al.Neuro-Oncology|April 6, 2021
Temozolomide-induced hypermutation is associated with distant recurrence and reduced survival after high-grade transformation of low-grade IDH-mutant gliomasYao Yu, Javier Villanueva-Meyer, Matthew R Grimmer, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2026
A genomically-tailored multi-agent precision medicine clinical trial for adults with recurrent glioblastomaJiaying Chen, Nancy Ann Oberheim Bush, Jennifer A Grabowsky, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 2023
Everolimus for Children With Recurrent or Progressive Low-Grade Glioma: Results From the Phase II PNOC001 TrialDaphne A Haas-Kogan, Mariam S Aboian, Jane E Minturn, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2020
Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent GlioblastomaLakshmi Nayak, Annette M Molinaro, Katherine Peters, et al.Proceedings of the National Academy of Sciences of the United States of America|July 24, 2023
An expandable, modular de novo protein platform for precision redox engineeringGeorge H Hutchins, Claire E M Noble, H Adrian Bunzel, et al.The Journal of Clinical Investigation|August 21, 2020
Mass cytometry detects H3.3K27M-specific vaccine responses in diffuse midline gliomaSabine Mueller, Jared M Taitt, Javier E Villanueva-Meyer, et al.Acta Neuropathologica|March 4, 2017
Adult infiltrating gliomas with WHO 2016 integrated diagnosis: additional prognostic roles of ATRX and TERTMelike Pekmezci, Terri Rice, Annette M Molinaro, et al.Acta Neuropathologica|March 1, 2015
Evolution of DNA repair defects during malignant progression of low-grade gliomas after temozolomide treatmentHinke F van Thuijl, Tali Mazor, Brett E Johnson, et al.Pageof 45